Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-31 @ 5:06 PM
Study NCT ID:
NCT07073833
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2025-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma
Sponsor:
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-26
First Submit QC Date:
None
Study First Post Date:
2025-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-16
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL